MedTrace Logo

Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)

NCT06202898 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2024-12-06

No results posted yet for this study

Summary

The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.

Conditions

  • Transgender Women
  • Aids
  • Hiv

Interventions

OTHER

Baseline

At the baseline visits, all study participants will be complete an interviewer-assisted questionnaire using REDCap, and will also receive the SBIRT-T MI-based intervention. Participants randomized to the ENTRUST intervention group will also be assigned to a cohort for strength sessions, and they will be provided with a schedule of strength session visits

OTHER

ENTRUST

Participants randomized to the ENTRUST intervention group will also be assigned to a cohort for economic strength sessions, group-based economic training through photovoice activities and adapted screening brief intervention and treatment (SBIRT-T) adapted for transgender women delivered by a facilitator or digitally.

OTHER

Control

participants assigned to the control arm will have the option of participating in the four additional strength sessions.

Sponsors & Collaborators

  • Sunserve

    collaborator UNKNOWN

  • Survivor's Pathway

    collaborator UNKNOWN

  • 26Health

    collaborator UNKNOWN

  • National Institute of Drug Abuse

    collaborator FED

  • University of Central Florida

    lead OTHER

Principal Investigators

  • Elena Cyrus, PhD · University of Central Florida

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-11
Primary Completion
2025-11-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06202898 on ClinicalTrials.gov